The Braskie Research Group focuses on the neuroimaging of Alzheimer’s disease (AD) risk and cognitive aging, with an emphasis on preclinical AD. In particular, we seek to better understand how genetic and environmental risk factors for AD - and their underlying biological mechanisms - relate to brain structure, function, pathology, and connectivity. To do this, we use relevant blood and cerebrospinal fluid measures and multimodal imaging, including structural and functional magnetic resonance imaging (MRI), diffusion imaging, and positron emission tomography (PET). We welcome collaborations with laboratories that are investigating similar concepts in a bench science environment.